(Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid

C26H28O12 — CID 163055475

IUPAC(Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid
SMILESCC1O[C@@H]2C[C@@H](O[C@H]3CC[C@H](O)[C@H](C)O3)[C@]1(O)c1c(O)c3c(c(O)c12)C(O)=C(/C=C\CC(=O)O)C(=O)C3=O
InChIInChI=1S/C26H28O12/c1-9-12(27)6-7-16(36-9)38-14-8-13-17-20(26(14,35)10(2)37-13)24(33)19-18(23(17)32)21(30)11(22(31)25(19)34)4-3-5-15(28)29/h3-4,9-10,12-14,16,27,30,32-33,35H,5-8H2,1-2H3,(H,28,29)/b4-3-/t9-,10?,12-,13+,14+,16-,26-/m0/s1
InChIKeySPWCLBWMLZVBIO-TVKLASSJSA-N
MW532.50 g/mol
LogP1.49
Rot. Bonds5

About (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid

(Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid (PubChem CID 163055475) has the molecular formula C26H28O12 and a molecular weight of 532.50 g/mol. Its IUPAC name is (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid.

Molecular Properties

Compound Name(Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid
PubChem CID163055475
Molecular FormulaC26H28O12
Molecular Weight532.50 g/mol
Exact Mass532.16
IUPAC Name(Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid
SMILESCC1O[C@@H]2C[C@@H](O[C@H]3CC[C@H](O)[C@H](C)O3)[C@]1(O)c1c(O)c3c(c(O)c12)C(O)=C(/C=C\CC(=O)O)C(=O)C3=O
InChIInChI=1S/C26H28O12/c1-9-12(27)6-7-16(36-9)38-14-8-13-17-20(26(14,35)10(2)37-13)24(33)19-18(23(17)32)21(30)11(22(31)25(19)34)4-3-5-15(28)29/h3-4,9-10,12-14,16,27,30,32-33,35H,5-8H2,1-2H3,(H,28,29)/b4-3-/t9-,10?,12-,13+,14+,16-,26-/m0/s1
InChIKeySPWCLBWMLZVBIO-TVKLASSJSA-N
XLogP1.49
TPSA200.28 Ų
H-Bond Donors6
H-Bond Acceptors11
Rotatable Bonds5
Heavy Atoms38
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500532.50
LogP ≤ 51.49
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_one_A(321)', 'substructure': 'N/A'}, {'alert_name': 'quinone_D(2)', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'hydroquinone', 'substructure': 'N/A'}

Analyze (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid?
The IUPAC name of (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid (CID 163055475) is (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid.
What is the SMILES notation for (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid?
The canonical SMILES for (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid is CC1O[C@@H]2C[C@@H](O[C@H]3CC[C@H](O)[C@H](C)O3)[C@]1(O)c1c(O)c3c(c(O)c12)C(O)=C(/C=C\CC(=O)O)C(=O)C3=O.
What is the InChIKey of (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid?
The InChIKey is SPWCLBWMLZVBIO-TVKLASSJSA-N. The full InChI is InChI=1S/C26H28O12/c1-9-12(27)6-7-16(36-9)38-14-8-13-17-20(26(14,35)10(2)37-13)24(33)19-18(23(17)32)21(30)11(22(31)25(19)34)4-3-5-15(28)29/h3-4,9-10,12-14,16,27,30,32-33,35H,5-8H2,1-2H3,(H,28,29)/b4-3-/t9-,10?,12-,13+,14+,16-,26-/m0/s1.
What are the key properties of (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid?
(Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid has a molecular weight of 532.50 g/mol, XLogP of 1.49, 5 rotatable bonds, 6 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (Z)-4-[(1S,12R,15R)-1,3,8,10-tetrahydroxy-15-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-14-methyl-5,6-dioxo-13-oxatetracyclo[10.2.2.02,11.04,9]hexadeca-2(11),3,7,9-tetraen-7-yl]but-3-enoic acid is sourced from PubChem (CID 163055475), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).